AzTrials
AzTrials

The Focus of Study is Description of a Very Rare CaseNCT06448741

Complete Penile and Testicular Self-amputation: a Very Rare Case

An observational study of The Focus of Study is Description of a Very Rare Case, run by Worabe Comprehensive Specialiazed Hospital at 1 site in Ethiopia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study is a case report on penile and testicular self-amputation. We didn't assign a drug of intervention. We tried to describe about this rare phenomenon by observation of the presentation and outcome. Read more about this study

Who is it for?
Any age, men only
What is being tested?
Replantation of amputated penis
How many people
1 participants
Where
1 siteEthiopia
Study dates
1 Feb 2024to 30 Mar 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Men only
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: we studied a single person with unique case

Inclusion Criteria: Patient with Penile and testicular self-amputation -

Exclusion Criteria: Patients with out Penile and testicular self-amputation

-

Trial locations and contacts

1 site in 1 country.

Ethiopia1 site
  • Worabe Comprehensive Specialized Hospital

    Worabe

Other trials in Ethiopia

About this study

The study is a case report on penile and testicular self-amputation. We didn't assign a drug of intervention. We tried to describe about this rare phenomenon by observation of the presentation and outcome.

Read the detailed description

We describe a very rare case of bilateral testicular and penile self-amputation by a psychiatric patient who came to our hospital after he amputated his penis and both of his testis. He was operated to replant his severed organs, but because of multiple reasons the replantation failed after 9 days of surgery. This kind of case is very rare, and it is our aim to disseminate the information about the case to physicians for better management in the future.

Being tested
Replantation of amputated penis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Replantation of amputated penisOther

    Replantation of the amputated penis done macroscopically, but testicular replantation was not done because of lack of microsurgical access

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Replantation

    successfully survival of replanted penis

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2024
  2. Study start1 Feb 2024
  3. Primary completion30 Mar 2024
  4. Study completion30 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
1 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06448741
Sponsor's protocol ID
Worabe Hospital
Status last verified
Jun 2024
First submitted
3 Jun 2024
Last updated
7 Jun 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of The Focus of Study is Description of a Very Rare Case, run by Worabe Comprehensive Specialiazed Hospital at 1 site in Ethiopia.

The full registered description is in the About this study section and the official record.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ethiopia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Replantation (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in